| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 3 |
| 1 | CAPECITABINE | 2 |
| 2 | CISPLATIN | 2 |
| 3 | FLUOROURACIL | 2 |
| 4 | FLUOROURACIL CREAM, 0.5% | 2 |
| 5 | OMEPRAZOLE MAGNESIUM | 2 |
| 6 | TRASTUZUMAB | 2 |
| 7 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 |
| 8 | 0XYGEN | 1 |
| 9 | ADALIMUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 1 | DROPERIDOL | 1 | 0.0006 |
| 2 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 | 0.0003 |
| 3 | RIPRETINIB | 1 | 0.0002 |
| 4 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 5 | LORLATINIB | 1 | 0.0001 |
| 6 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 1 | 0.0001 |
| 7 | BUPIVACAINE | 1 | 0.0001 |
| 8 | EPTINEZUMAB-JJMR | 1 | 0.0001 |
| 9 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 2 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 8 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 3 | 0.0000 |